PhysIOL

PhysIOL is a Belgium-based medical technology company that specializes in the research, development, manufacture, and marketing of intraocular lenses (IOLs) primarily used in cataract surgery. Founded in 1986, the company has built extensive expertise in the entire value chain of IOL production, including polymer chemistry and sterilization processes. With a strong focus on innovation, PhysIOL maintains a dynamic R&D department that collaborates with ophthalmic surgeons and research institutions to create advanced optical solutions. The company’s product portfolio includes high-quality intraocular implants designed to replace the natural lens removed during cataract surgery, helping to restore vision for patients worldwide. Headquartered in Liège, Belgium, PhysIOL serves a global customer base that includes hospitals, eye clinics, and ophthalmic surgeons. The company was acquired by Beaver-Visitec International in 2018, which has supported its growth in the medical products industry. PhysIOL employs between 51 and 200 people and is committed to advancing ophthalmic care through its innovative solutions.

• Employees 92
• Founded 1986
• Annual Revenue $55130000